My thoughts are that we will work to possibly produce our own TAVR valve, to implant such a device requires minimally invasive surgical procedures, the old damaged valve can be left in place.
Surgical repair of the valve would make more sense in younger patients and if our tissue holds up well this would mean the patient could possibly live on without return surgery, TAVR for older individuals where risk's from surgical complication should be kept to a minimum.
I'm no expert in this area (I play with HV electricity) so I would be interested to hear other opinions.
Perhaps we could licence out Adapt to the big guys or provide Adapt tissue? who knows..
TAVR & Reflections, page-3
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 475 | $18.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.91 | 100 | 1 |
View Market Depth
| Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |